Login / Signup

A possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs.

Takahito DoiAnne LangstedBørge Grønne Nordestgaard
Published in: European heart journal (2021)
The contrasting results of REDUCE-IT vs. STRENGTH can partly be explained by a difference in the effect of comparator oils (mineral vs. corn), but not of active oils [eicosapentaenoic acid (EPA) vs. EPA + docosahexaenoic acid], on lipid traits and C-reactive protein. The unexplained additional 13% risk reduction in REDUCE-IT likely is through other effects of EPA or mineral oil.
Keyphrases
  • fatty acid
  • clinical trial
  • study protocol
  • randomized controlled trial
  • gene expression
  • phase ii